White Paper

Taking Charge of Pharmacy with Proven Cost Containment Strategies

This white paper shares proven strategies to control pharmacy costs, reduce overspending, and improve outcomes by tackling high drug prices, overprescribing, compliance risks, and fraud.
By:

White Paper Summary

Are hidden pharmacy costs inflating your claim spend? This white paper uncovers leakage from unmanaged out-of-network prescriptions to costly high-impact drugs, and how a fully integrated approach can capture every dollar. Proven strategies combine real-time management, early intervention, and targeted drug identification to cut your pharmacy costs while improving patient recovery. If controlling total claim costs is your priority, this is your blueprint for eliminating waste, closing cost leaks, and maximizing savings.

Register to download the full content

 

To learn more from Enlyte, please visit their website.

Enlyte is the parent brand of Mitchell | Genex | Coventry, a leader in cost-containment technology, independent medical exams (IME), provider and specialty networks, case management services, pharmacy benefit and disability management. The three businesses have recently aligned their joint industry expertise and advanced technology solutions into a combined organization of nearly 6,000 associates committed to simplifying and optimizing property, casualty and disability claims processes and services.